Znrf3tm1.1Npa
Targeted Allele Detail
|
|
| Symbol: |
Znrf3tm1.1Npa |
| Name: |
zinc and ring finger 3; targeted mutation 1.1, Novartis Pharma AG |
| MGI ID: |
MGI:6724094 |
| Synonyms: |
Znrf3lox |
| Gene: |
Znrf3 Location: Chr11:5226329-5394847 bp, - strand Genetic Position: Chr11, 3.46 cM
|
| Alliance: |
Znrf3tm1.1Npa page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:236636
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted into intron 6 and a second loxP site into intron 7. The loxP sites are approximately 0.7 kb apart and flank RING domain coding exon 7. The FRT site flanked neomycin resistance gene cassette that was also inserted, was removed through subsequent flp-mediated recombination.
(J:236636)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Znrf3 Mutation: |
45 strains or lines available
|
|
| Original: |
J:236636 Planas-Paz L, et al., The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol. 2016 May;18(5):467-79 |
| All: |
1 reference(s) |
|